[Endocrinologic action spectrum of 19-nor-17-alpha-hydroxyprogesterone capronate (Gestonorone capronate)].
D000022:Abortion, Spontaneous / Q000517:prevention & control*; D000311:Adrenal Glands / Q000187:drug effects; D000726:Androgen Antagonists; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology; D002208:Caproates; D002369:Castration; D004702:Endocrine Glands / Q000187:drug effects*; D004717:Endometrium / Q000187:drug effects; D004965:Estrogen Antagonists; D005260:Female; D005262:Feminization / Q000139:chemically induced; D006908:Hydroxyprogesterones / Q000494:pharmacology*; D008297:Male; D051379:Mice; D010060:Ovulation / Q000187:drug effects; D010121:Oxytocin / Q000037:antagonists & inhibitors; D010227:Parabiosis / Q000187:drug effects; D010902:Pituitary Gland / Q000187:drug effects; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000187:drug effects*; D011374:Progesterone / Q000494:pharmacology*; D011372:Progestins / Q000494:pharmacology*; D011817:Rabbits; D051381:Rats; D013737:Testis / Q000187:drug effects; D014770:Virilism / Q000139:chemically induced
D000726:Androgen Antagonists; D000893:Anti-Inflammatory Agents; D002208:Caproates; D004965:Estrogen Antagonists; D006908:Hydroxyprogesterones; D011372:Progestins; D011374:Progesterone; D010121:Oxytocin
Das endokrinologische Wirkungsspektrum von 19-Nor-17-alpha-hydroxy-progesteroncapronat (Gestonoroncapronat)